2024 ESC Guidelines for the management of chronic coronary syndromesChristiaan Vrints, John W. McEvoy, Jan J. Piek et al.|European Heart Journal|2024Cited by 2.3k
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics studyFátima Sánchez‐Cabo, Enrique Lara‐Pezzi, Valentı́n Fuster et al.|European Heart Journal|2023Cited by 124
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trialPK Judge, A. Q. Adeleke, Natalie Staplin et al.|The Lancet Diabetes & Endocrinology|2023Cited by 107
Clinical Phenotypes of Acute Heart Failure Based on Signs and Symptoms of Perfusion and Congestion at Emergency Department Presentation and their Relationship with Patient Management and OutcomesPatricia Javaloyes, Pere Llorens, Òscar Miró et al.|European Journal of Heart Failure|2019Cited by 105
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trialsXavier Rosselló, John Munkhaugen, Eva Prescott et al.|The Lancet|2025Cited by 63